Comments
The ₹100-crore buyback offer from Ajanta Pharma will open for subscription on Thursday and close on March 14. It plans to buy back 7.69 lakh shares (representing 0.87 per cent of its total paid-up equity capital) at ₹1,300 a share. Shareholders whose names had appeared on its record books on February 12 (record date) are eligible to participate in the buyback, being done via the tender offer route. Certain members of the promoter group are willing to participate in the buyback.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.